MEDIZIN — JOURNAL CLUB
Autor: Valérie Herzog
MEDIZIN — JOURNAL CLUB
Gingko bei Schwindel
MEDIZIN — JOURNAL CLUB
Hyponatriämierisiko bei Thiaziddiuretika
MEDIZIN — JOURNAL CLUB
Massenhaft gefälschte Literaturangaben entdeckt
MEDIEN - MODEN - MEDIZIN
Rückenmarksverletzung: Antikörper lässt Nervenfasern neu wachsen
Eine internationale Studiengruppe unter der Leitung der Universität Zürich (UZH) und der Universitätsklinik Balgrist hat Patienten mit akuten Rückenmarksverletzungen erfolgreich mit dem neuartigen Antikörper NG101 behandelt. Die Ergebnisse zeigten, dass NG101 die Rückbildung von Rückenmarksläsionen beschleunigt und bestehendes Nervengewebe erhält.
Cardiology Review Course Zurich 2026: What is Required for Optimal Lipid Management
Given the risks associated with elevated lipid levels, optimal lipid management is of great importance. Prof. Dr. Isabella Sudano, head of the hypertension,
dyslipidemia, and smoking cessation clinic, Department of Cardiology, University Hospital of Zurich; and PD Dr. Kon- stantinos Koskinas, Preventive Cardiology, University Clinic for Cardiology, Inselspital Bern, at the Cardiology Review Course Zurich 2026.
Journal Club
No Need to Give up Coffee after Cardioversion
It is commonly believed that caffeinated coffee has a proar- rhythmic effect. A prospective, open-label, randomized study investigated whether caffeinated coffee has an influence on recurrent atrial fibrillation compared to abstinence from coffee and caffeine.
Nicotine in any Form Is Harmful to the Heart
Regardless of whether nicotine is burned, heated, inhaled, or simply kept in the mouth as a pouch, the European Society of Cardiology classifies nicotine as a direct cardiovascular toxin in a consensus paper. This assessment was based on an evaluation of all available literature on nicotine consumption.
Colchicine for Heart Attacks
Treatment with low-dose colchicine has been proposed for secondary cardiovascular prevention in patients with high cardiovascular risk. A Cochrane review investigated the benefits of colchicine therapy in patients with stable cardiovascular disease, previous myocardial infarction, or stroke. Twelve randomized placebo-controlled studies with a total of 22,983 participants aged between 57 and 74 years were evaluated.
Comparison of Anticoagulants
Apixaban and rivaroxaban are the most commonly used oral anticoagulants for the treatment of acute venous thromboembolism. An international study with a prospective, randomized, open-label, and blinded endpoint design investigated the extent to which the risk of bleeding differs between the two anticoagulants.